Position in LXRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$57,031
New position
Shares Held
23,763
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 148 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,846,021 across 121 Biotechnology names. LXRX ranks #104 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in LXRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,031 | 23,763 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||